MHE Question of the Week: Your Opinion of the Change Healthcare Cyberattack
Share your view about the Change Healthcare cyberattack.
Change Healthcare, a revenue cycle and healthcare analytics company now part of UnitedHealth Group’s Optum division, was cyberattacked on Feb. 21, according to a Securities and Exchange Commission (SEC) filing by UnitedHealth. To contain the attack, Change Healthcare’s information systems were disconnected. UnitedHealth said in the SEC filing that a “suspected nation-state associated cyber security threat actor” had been identified but hasn’t released any information on the perpetrator since. The outage has affected pharmacies throughout the country, including those at some military medical facilities. The American Hospital Association recommended that all healthcare organizations disrupted or “potentially exposed by this incident” consider disconnection from Optum. Numerous status updates on the situation on an Optum website, including one this morning at 8:04 a.m. EST, have said, "we have a high level of confidence that Optum, UnitedHealthcare and UnitedHealth Group systems have not been affected by this issue.”
Please pick the statement that most closely resembles your opinion of the Change Healthcare cyberattack
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More
